Cellnovo Stock

Stocks

CLNV

FR0012633360

Software

Real-time Euronext Paris 5-day change 1st Jan Change
- EUR -.--% Intraday chart for Cellnovo -.--% -

Valuation: Cellnovo

Market Cap 2.44M 2.13M 1.97M 1.84M 3.46M 230M 3.54M 23.64M 9.14M 114M 9.15M 8.94M 394M P/E 2018 *
-0.15x
P/E 2019 * -
Enterprise Value 12.46M 10.9M 10.06M 9.39M 17.7M 1.18B 18.08M 121M 46.73M 581M 46.78M 45.75M 2.02B EV / Sales 2018
8.63x
EV / Sales 2019 * -
Free-Float
99.67%
Yield 2018 *
-
Yield 2019 * -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 2.68M
-1.47%-4.29%-31.49%+11.67% 15.33B
-0.77%+13.93%+27.18%+42.42% 7.64B
+0.23%-5.15%-49.31%-62.06% 7.31B
+11.64%+10.19%-17.44%+257.41% 3.95B
+12.70%+8.52%-29.72%-39.74% 2.03B
+0.60%-5.40%-38.56%-48.77% 1.71B
+1.85%+4.08%-8.38%+27.74% 1.53B
+1.57%+1.99%+3.80%+73.32% 1.48B
+1.03%+2.15%-7.29%+74.52% 1.18B
Average +2.75%+0.42%-16.80%+37.39% 4.22B
Weighted average by Cap. +1.26%-0.36%-20.08%+27.07%

Financials

2018 2019 *
Net sales 3.32M 2.91M 2.68M 2.51M 4.72M 314M 4.82M 32.24M 12.46M 155M 12.47M 12.2M 538M -
Net income -15.94M -13.95M -12.87M -12.02M -22.64M -1.51B -23.14M -155M -59.79M -743M -59.85M -58.54M -2.58B -
Net Debt 10.02M 8.77M 8.09M 7.56M 14.24M 947M 14.55M 97.28M 37.59M 467M 37.63M 36.81M 1.62B -
Logo Cellnovo
Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development of a mobile system for managing type 1 diabetes. Its apparatus includes a cordless micro-pump (a patch pump), an integrated monitoring device and a cellular handset with touch screen with an embedded blood glucose meter. The Company system enables diabetics to live a normal life whilst closely monitoring their glycaemia, their use of insulin, their activity and their food intake.
Employees
-
  1. Stock Market
  2. Stocks
  3. CLNV Stock